✦ LIBER ✦

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

✍ Scribed by R. Channick; D.B. Badesch; V.F. Tapson; G. Simonneau; I. Robbins; A. Frost; S. Roux; M. Rainisio; F. Bodin; L.J. Rubin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of the dual endothelin-receptor

✍ R.N. Channick; G. Simonneau; O. Sitbon 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Effects of the dual endothelin-receptor

✍ Richard N Channick; Gérald Simonneau; Olivier Sitbon; Ivan M Robbins; Adaani Fro 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 90 KB

Effects of the oral endothelin-receptor

✍ N. Galie; A.L. Hinderliter; A. Trobicki; T. Fourme 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 35 KB

232: Treatment of Pulmonary Hypertension

✍ U. Schulz; G. Tenderich; S. Schulte-Eistrup; R. Koerfer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Effect of the dual endothelin receptor a

✍ Fátima Álvarez Reyes; Cristina Luna Gómez; Manuel Brito Suárez 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 670 KB

523 HEMODYNAMIC EFFECTS OF TEZOSENTAN, A

✍ D. Lebrec; J. Bosch; R. Jalan; F.J. Dudley; R. Jesic; J.C. Garcia-Pagan; R. Mook 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB